MMP9 and triple-A syndrome: Biological activities of IL-8 change upon site-specific proteolytic modification, mediated by MMP9 and other metalloproteinases, whose deregulation in pathological conditions like AAA supports the relevance of IL-8 cleavage in inflammatory settings [29].